Recent advancement in the discovery and development of COX-2 inhibitors: Insight into biological activities and SAR studies (2008–2019)

Chandrasekharan, 2002, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. USA, 99, 13926, 10.1073/pnas.162468699

V. Kumar, A.K. Abbas, J.C. Aster, Robbins & Cotran Pathologic Basis of Disease, Elsevier, South Asia ed., 2014, pp. 85.

Hinz, 2002, Cyclooxygenase-2–10 years later, J. Pharmacol. Exp. Ther., 300, 367, 10.1124/jpet.300.2.367

Zimmermann, 1998, Constitutive cyclooxygenase-2 expression in healthy human and Rabbit Gastric Mucosa, Mol. Pharmacol., 54, 536, 10.1124/mol.54.3.536

Mizuno, 1997, Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice, Gastroenterology, 112, 387, 10.1053/gast.1997.v112.pm9024292

Jones, 1999, Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing, Nat. Med., 5, 1418, 10.1038/70995

Harris, 1994, Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction, J. Clin. Invest., 94, 2504, 10.1172/JCI117620

Zembowicz, 1995, Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine, J. Clin. Invest., 96, 1688, 10.1172/JCI118211

Martínez-González, 2007, Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks, Curr. Pharm. Des., 13, 2215, 10.2174/138161207781368774

Kirkby, 2014, COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks, PLoS One, 9, 10.1371/journal.pone.0098165

Lim, 1997, Multiple female reproductive failures in cyclooxygenase 2-deficient mice, Cell, 17, 197, 10.1016/S0092-8674(00)80402-X

Didolkar, 1980, Effect of aspirin on spermatogenesis in mature and immature rats, Int. J. Androl., 3, 585, 10.1111/j.1365-2605.1980.tb00146.x

Rumzhum, 2016, Cyclooxygenase 2: its regulation, role and impact in airway inflammation, Clin. Exp. Allergy, 46, 397, 10.1111/cea.12697

Yap, 2015, Non-steroidal anti-inflammatory drugs (NSAIDs) induced Dyspepsia, Curr. Pharm. Des., 21, 5073, 10.2174/1381612821666150915105738

Misra, 2014, COX-2 signaling and cancer: new players in old arena, Curr. Drug Targets, 15, 347, 10.2174/1389450115666140127102915

Chandel, 2017, Investigations on antioxidant, antiproliferative and COX-2 inhibitory potential of alkaloids from Anthocephalus cadamba (Roxb.), Miq. Leaves. Chem Biodivers., 14

Yang, 2009, Phenolic compounds with radical scavenging and cyclooxygenase-2 (COX-2)inhibitory activities from Dioscorea opposita, Bioorg. Med. Chem., 17, 2689, 10.1016/j.bmc.2009.02.057

Makkar, 2018, Previously undescribed antioxidative azocinyl morpholinone alkaloid from red seaweed Gracilaria opuntia with anti-cyclooxygenase and lipoxygenase properties, Nat. Prod. Res., 32, 1150, 10.1080/14786419.2017.1326041

Kiraly, 2016, Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice, Prostaglandins Leukot. Essent. Fat. Acids, 104, 44, 10.1016/j.plefa.2015.11.006

Li, 2011, Primary virtual and in vitro bioassay screening of natural inhibitors from flavonoids against. COX-2, Chin. J. Nat. Sci., 9, 156

Rimando, 2002, Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol, J. Agric. Food Chem., 50, 3453, 10.1021/jf0116855

Zhang, 2005, Cyclooxygenase-2 enzyme inhibitory triterpenoids from Picrorhiza kurroa seeds, Life sci., 77, 3222, 10.1016/j.lfs.2005.05.051

Zou, 2005, Selective cyclooxygenase-2 inhibitors from Calophyllum membranaceum, J. Nat. Prod., 68, 1514, 10.1021/np0502342

Gupta, 2008, Exploration of physicochemical properties and molecular modelling studies of 2-sulfonyl-phenyl-3-phenyl-indole analogs as cyclooxygenase-2 inhibitors, Eur. J. Med. Chem., 43, 1297, 10.1016/j.ejmech.2007.06.022

Palomer, 2002, Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models, J. Med. Chem., 45, 1402, 10.1021/jm010458r

Riendeau, 1994, Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets, J. Biol. Chem., 269, 15619, 10.1016/S0021-9258(17)40726-5

Kato, 2001, Cyclooxygenase-1 and cyclooxygenase-2 selectivity of nonsteroidal anti-inflammatory drugs: investigation using human peripheral monocytes, J. Pharm. Pharmacol., 53, 1679, 10.1211/0022357011778070

Waterbury, 2006, Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium, Curr. Med. Res. Opin., 22, 1133, 10.1185/030079906X112471

Daham, 2014, Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma, J. Allergy Clin. Immunol., 134, 306, 10.1016/j.jaci.2013.12.002

Fan, 2015, Differential expression of COX-2 in osteoarthritis and rheumatoid arthritis, Genet. Mol. Res., 14, 12872, 10.4238/2015.October.21.7

Tsujii, 1998, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell, 93, 705, 10.1016/S0092-8674(00)81433-6

Martinet, 2010, PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling, Biochem. Pharmacol., 15, 838, 10.1016/j.bcp.2010.05.002

Yao, 2004, Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer, Br. J. Cancer, 90, 712, 10.1038/sj.bjc.6601489

Hoozemans, 2005, The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs, Curr. Drug Targets CNS Neurol. Disord., 4, 307, 10.2174/1568007054038201

Pasinetti, 2001, Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia, Arch. Gerontol. Geriatr., 33, 13, 10.1016/S0167-4943(01)00091-7

Müller, 2008, COX-2 inhibition in schizophrenia and major depression, Curr. Pharm. Des., 14, 1452, 10.2174/138161208784480243

Lin, 2017, Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents, Sci. Rep., 7, 44701, 10.1038/srep44701

Morham, 1995, Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell, 83, 473, 10.1016/0092-8674(95)90125-6

Hoffmann, 2000, COX-2 in brain and spinal cord implications for therapeutic use, Curr. Med. Chem., 7, 1113, 10.2174/0929867003374282

Lim, 1997, Multiple female reproductive failures in cyclooxygenase 2-deficient mice, Cell, 91, 197, 10.1016/S0092-8674(00)80402-X

Crankshaw, 1994, Effects of some naturally occurring prostanoids and some cyclooxygenase inhibitors on the contractility of the human lower uterine segment in vitro, Can. J. Physiol. Pharmacol., 72, 870, 10.1139/y94-123

Reuter, 1996, Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2, J. Clin. Invest., 98, 2076, 10.1172/JCI119013

Kirkby, 2016, Systematic study of constitutive cyclooxygenase-2 expression: role of NF-κB and NFAT transcriptional pathways, Proc. Natl. Acad. Sci. USA, 113, 434, 10.1073/pnas.1517642113

Engelhardt, 2006, Synthesis of a NO-releasing prodrug of rofecoxib, J. Org. Chem., 71, 480, 10.1021/jo051712g

Suthar, 2015, Recent developments in chimeric NSAIDs as safer anti-inflammatory agents, Med. Res. Rev., 35, 341, 10.1002/med.21331

Gilroy, 1999, Inducible cyclooxygenase may have anti-inflammatory properties, Nat. Med., 5, 698, 10.1038/9550

Bertolini, 2002, Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks, Curr. Med. Chem., 9, 1033, 10.2174/0929867024606650

Willoughby, 2000, COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease, Lancet., 355, 646, 10.1016/S0140-6736(99)12031-2

Daham, 2011, Effects of celecoxib on major prostaglandins in asthma, Clin. Exp. Allergy, 41, 36, 10.1111/j.1365-2222.2010.03617.x

Wallace, 1998, Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity, Gastroenterology, 115, 101, 10.1016/S0016-5085(98)70370-1

Chen, 2008, Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis, Arthr. Rheum., 58, 1354, 10.1002/art.23453

Matsumoto, 1997, Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages, Biochem. Biophys. Res. Commun., 230, 110, 10.1006/bbrc.1996.5894

Smith, 1998, Pharmacological analysis of cyclooxygenase-1 in inflammation, Proc. Natl. Acad. Sci. USA, 95, 13313, 10.1073/pnas.95.22.13313

Myers, 2000, The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis, Arthr. Rheum., 43, 2687, 10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9

Garavito, 2002, The structures of prostaglandin endoperoxide H synthases-1 and -2, Prostaglandins Other LipidMediat., 68–69, 129, 10.1016/S0090-6980(02)00026-6

A.A. Siddiqui, Precise Chemistry of Natural Products and Heterocyclic Compounds, CBS Publishers & Distributors Pvt. Ltd., first ed., 2014, pp. 428.

Tang, 2013, Nickel-catalyzed oxidative cyclotrimerization of α-amino ketones: selective synthesis of pyrazoles, Synlett, 25, 64, 10.1055/s-0033-1340014

Katritzky, 1987, The mechanisms of heterocyclic ring closures, Tetrahedron, 43, 5171, 10.1016/S0040-4020(01)87693-6

Yoon, 2011, Recent advances in the regioselective synthesis of pyrazoles, Curr. Org. Chem., 15, 657, 10.2174/138527211794519005

Wiley, 1951, 3,5-dimethylpyrazole, Org. Synth., 31, 43, 10.15227/orgsyn.031.0043

K. Ando, K. Kawamura, Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents, US6603008B1, 05 August, 2003.

R. Betageri, C.L. Cywin, K. Hargrave, M.A. Hoermann, T.M. Kirrane, T.M. Parks, U.R. Patel, J.R. Proudfoot, R. Sharma, S. Sun, X.J. Wang, Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents, US6506747B1, 14 January, 2003.

S.M. Sakya, B. Rast, Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents, US6900230B2, 31 May, 2005.

H. Cheng, J.K. Dutra, S.M. Sakya, Pyrazole ether derivatives as anti-inflammatory/analgesic agents, WO2001064669A1, 07 September, 2001.

K.M. Lundy, H. Cheng, S.M. Sakya, J. Li, M.L. Minich, C. Uchida, Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents, US6531492B1, 11 March, 2003.

K. Ando, M.L. Minich, J. Li, S.M. Sakya, K.M. Lundy, H. Cheng, B.S. Bronk, K. Kawamura, T. Kato, Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents, US6649636B1, 18 November, 2003.

M.R. Bell, Anti-inflammatory 8H-phenanthro-[2,3-c]pyrazole derivatives, US4349558A, 14 September, 1982.

J.J. Talley, Rogier D.J.J, 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation. US5434178A, 18 July, 1998.

L.F. Lee, T.D. Penning, S.W. Kramer, 3,4-substituted pyrazoles for the treatment of inflammation, US5486534A, 23 January, 1996.

M. Hirano, K. Nakao, S. Nuki, T. Yamagishi, Pyrazole compounds as anti-inflammatory and analgesic agents, US7001917B2, 12 April, 2002.

H. Numata, Y. Okamoto, M. Shinoda, N. Kobayashi, S. Miyazawa, T. Kawahara, H. Shirota, N. Nagakura, T. Horizoe, S. Abe, S. Kobayashi, T. Yamanaka, Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects, WO1996014302A1 17 June, 1996.

J.J. Talley, T.D. Penning, P.W. Collins, D.J. Rogier Jr., J.W. Malecha, J.M. Miyashiro, S.R. Bertenshaw, I.K. Khanna, M.J. Graneto, R.S. Rogers, J.S. Carter, S.H. Docter, S.S. Yu, Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation, 02 June, 1998.

Alam, 2016, Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues, Drug Des. Devel. Ther., 10, 3529, 10.2147/DDDT.S118297

Alegaon, 2014, 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents, Bioorg. Chem., 54, 51, 10.1016/j.bioorg.2014.04.001

Faidallah, 2017, Synthesis, anti-inflammatory activity, and COX-2 inhibition profile of some novel non-acidic polysubstituted pyrazoles and Pyrano[2,3-c]pyrazoles, Arch. Pharm. (Weinheim), 350, 10.1002/ardp.201700025

Shen, 2017, Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX, Bioorg. Med. Chem. Lett., 27, 3653, 10.1016/j.bmcl.2017.07.020

Ghareb, 2017, Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; ultrasound-assisted synthesis, biological evaluation, and DFT calculations, Bioorg. Med. Chem. Lett., 27, 2377, 10.1016/j.bmcl.2017.04.020

Bashir, 2011, Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents, Bioorg. Med. Chem. Lett., 21, 4301, 10.1016/j.bmcl.2011.05.061

Amir, 2008, Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents, Bioorg. Med. Chem. Lett., 18, 918, 10.1016/j.bmcl.2007.12.043

Bakr, 2016, Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new1-phenylpyrazolo[3,4-d]pyrimidine derivatives, J. Enzyme Inhib. Med. Chem., 31, 6, 10.1080/14756366.2016.1186018

Abdellatif, 2019, Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors, Bioorg. Chem., 82, 86, 10.1016/j.bioorg.2018.09.034

El-Shoukrofy, 2019, Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies, Bioorg. Chem., 85, 541, 10.1016/j.bioorg.2019.02.036

Ren, 2018, Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy, Eur. J. Med. Chem., 157, 909, 10.1016/j.ejmech.2018.08.048

Inceler, 2018, Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents, Med. Chem. Comm., 9, 795, 10.1039/C8MD00022K

Fischer, 1883, Ueber die Hydrazine der Brenztraubensäure, Ber Dtsch Chem. Ges., 16, 2241, 10.1002/cber.188301602141

Fukuyama, 1994, A novel tin-mediated indole synthesis, J. Am. Chem. Soc., 116, 3127, 10.1021/ja00086a054

Bischler, 1892, Ueber die Entstehung einiger substituirter Indole, Ber Dtsch Chem. Ges., 25, 2860, 10.1002/cber.189202502123

Batcho, 1985, Indoles from 2-methylnitrobenzenes by condensation with formamide acetals followed by reduction: 4-benzyloxyindole, Org. Synth., 63, 214, 10.15227/orgsyn.063.0214

Nenitzescu, 1929, Derivatives of 2-methyl-5-hydroxyindole, Bull. Soc. Chim. Roman., 11, 37

Bayer, 1869, Synthese des indoles, Ber. Dtsch. Chem. Ges., 2, 679, 10.1002/cber.186900201268

Madelung, 1912, Über eine neue Darstellungsweise für substituierte Indole, I. Ber. Dtsch. Chem. Ges., 45, 1128, 10.1002/cber.191204501160

Gassman, 1973, Use of halogen-sulfide complexes in the synthesis of indoles, oxindoles, and alkylated aromatic amines, J. Am. Chem. Soc., 95, 6508, 10.1021/ja00800a088

Hemetsberger, 1972, Synthese und Thermolyse von α-Azidoacrylestern, Monatsh. Chem., 103, 194, 10.1007/BF00912944

Larock, 1991, Synthesis of indoles via palladium-catalyzed heteroannulation of internal alkynes, J. Am. Chem. Soc., 113, 6689, 10.1021/ja00017a059

K. Nakao, S. Hayashi, R.W. Stevens, Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents, US6303628B1, 16 October, 2001.

K. Nakao, R.W. Stevens, K. Kawamura, C. Uchida, Substituted indole compounds as anti-inflammatory and analgesic agents, US6277878B1, 21 August, 2001.

C.A. Broka, J.A. Campbell, Indole derivatives as anti-inflammatory agents, US6872744B2, 29 March, 2005.

A.W. Faull, J. Kettle, Anti-inflammatory indole derivatives, WO2000046195A1, 10 August, 2001.

R. Sharma , Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents, US6353007B1, 05 March, 2002.

O.J. McConnell, G. Saucy, R. Jacobs, Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof, WO1994019343A, 01 September, 1994.

W.H. Gerwick, R. Castenholz, F. Garcia-Pichel, P.J. Proteau, Indole alkaloids useful as UV protective and anti-inflammatory agents, US5508026A, 16 April, 1996.

P.E. Driedger, J. Quick, Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity, US5962498A 05 October, 1999.

R.W. Stevens, K. Nakao, K. Kawamura, C. Uchida, S. Fujiwara, Indole compounds as COX-2 inhibitors, US6300363B1 09 October, 2001.

J.R. Sorenson, Anti-inflammatory and anti-ulcer compounds and process, US5521171A, 28 May, 1996.

R.S. Jacobs, S. Pomponi, S. Gunasekera, A. Wright, Anti-neurogenic inflammatory compounds and compositions and methods of use thereof, WO1998018466A2, 07 May, 1998.

C.A. Broka, J.A. Campbell, Indole derivatives as anti-inflammatory agents, US7074939B2, 11 July, 2006.

Lamie, 2016, Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: synthesis, biological activities in vitro and docking study, Eur. J. Med. Chem., 123, 803, 10.1016/j.ejmech.2016.08.013

Kaur, 2012, N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation, Bioorg. Med. Chem. Lett., 22, 2154, 10.1016/j.bmcl.2012.01.130

Bhat, 2018, Indole derivatives as cyclooxygenase inhibitors: synthesis, biological evaluation and docking studies, Molecules, 23, 6, 10.3390/molecules23061250

Estevão, 2012, Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening, Eur. J. Med. Chem., 54, 823, 10.1016/j.ejmech.2012.06.040

Abdellatif, 2016, 3-methyl-2-phenyl-1-substituted-indolederivatives as indomethacin analogs: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents, J. Enzyme Inhib. Med. Chem., 31, 318, 10.3109/14756366.2015.1022174

Özdemir, 2015, Synthesis and evaluation of new indole-based chalcones as potential antiinflammatory agents, Eur. J. Med. Chem., 89, 304, 10.1016/j.ejmech.2014.10.056

Hayashi, 2014, Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs, J. Enzyme Inhib. Med. Chem., 29, 846, 10.3109/14756366.2013.864650

Hayashi, 2012, Novel acid-type cyclooxygenase-2 inhibitors: design, synthesis, and structure-activity relationship for anti-inflammatory drug, Eur. J. Med. Chem., 50, 179, 10.1016/j.ejmech.2012.01.053

Lai, 2010, Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors, Bioorg. Med. Chem. Lett., 20, 7349, 10.1016/j.bmcl.2010.10.056

Kaur, 2018, Design and Synthesis of Aza-/Oxa heterocycle-based conjugates as novel anti-inflammatory agents targeting Cyclooxygenase-2, ACS Omega, 3, 5825, 10.1021/acsomega.8b00445

Amin, 2018, Anti-inflammatory indomethacin analogs endowed with preferential COX-2 inhibitory activity, Future Med. Chem., 10.4155/fmc-2018-0224

Naaz, 2018, 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: their anti-proliferative & anti-inflammatory activity, Bioorg. Chem., 81, 1, 10.1016/j.bioorg.2018.07.029

Blobaum, 2013, The 2'-trifluoromethyl analogue of indomethacin is a potent and selective COX-2 inhibitor, ACS Med. Chem. Lett., 4, 486, 10.1021/ml400066a

Moraes, 2018, Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives, Bioorg. Med. Chem., 26, 5388, 10.1016/j.bmc.2018.07.024

Swathi, 2017, Development of novel indole molecules for the screening of anti-inflammatory activity, Adv. Exp. Med. Biol., 988, 139, 10.1007/978-3-319-56246-9_11

Antonyraj, 2008, Hantzsch pyridine synthesis using hydrotalcites or hydrotalcite-like materials as solid base catalysts, Appl. Catal. A: Gener., 338, 121, 10.1016/j.apcata.2007.12.028

Skell, 1958, Reactions of 1,1-dihalocyclopropanes with electrophilic reagents. Synthetic route for inserting a carbon atom between the atoms of a double Bond, J. Am. Chem. Soc., 80, 2024, 10.1021/ja01541a070

Bönnemann, 1978, Cobalt-catalyzed pyridine syntheses from alkynes and nitriles, Angew. Chem. Int. Ed. Engl., 17, 505, 10.1002/anie.197805051

Kroehnke, 1976, The specific synthesis of pyridines and oligopyridines, Synthesis, 1–24

Gattermann, 1916, Eine Synthese von Pyridin-Derivaten, Ber. Dtsch. Chem. Ges., 49, 494, 10.1002/cber.19160490155

Chichibabin, 1924, Über Kondensation der Aldehyde mit Ammoniak zu, Pyridinebasen J. Prakt Chem., 107

D. Dube, R. Fortin, R. Friesen, Z. Wang, J.Y. Gauthier, Substituted pyridines as selective cyclooxygenase-2 inhibitors, US7060715B2, 13 June, 2006.

I.W. Davies, M. Journet, L. Gerena, R.D. Larsen, P.J. Pye, K. Rossen, Process for making diaryl pyridines useful as cox-2-inhibitors, US6369275B1, 09 April, 2002.

T.T. Kararli, M.J. Kontny, S. Desai, M.J. Hageman, R.J. Haskell, Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect, US7172769B2, 06 February, 2007.

I.H. Cho, J.W. Lim, J.Y. Noh, J.H. Kim, S.W. Park, H.C. Ryu, J.H. Kim, J.H. Kim, S.Y. Wang, D.H. Kim, Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor, WO2003055874A1, 10 July, 2003.

R. Friesen, R. Fortin, D. Dube, D. Deschenes , 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2, US6046217A, 04 April, 2000.

P. Beswick, N. Pegg, M. Swarbrick, J. Skidmore, S. Modi, Cox-2 inhibiting pyridine derivatives, US7446117B2, 04 November, 2008.

B. Buettelmann, R. Jakob-Roetne, H. Knust, M.C. Lucas, A. Thomas, Isoxazolo-pyridine derivatives, US8877782B2, 04 November, 2014.

C. Black, Z. Wang, G. Hughes, Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors, US5922742A, 13 July, 1999.

R.M. Weier, L.F. Lee, R.A. Partis, F.J. Koszyk, 2,3-substituted pyridines for the treatment of inflammation, US5916905A, 29 June, 1999.

I.B. Campbell, A. Naylor, Pyrazolopyridine derivatives as selective cox-2 inhibitors, US7223772B1, 29 May, 2007.

F.C.A. Gaeta, M. Gross, K.W. Johnson, Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use, US7585875B2, 08 September, 2009.

P.J. Pye, A. Maliakal, K. Rossen, R.P. Volante, J. Sager, Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors, US6130334A, 10 October, 2000.

Badrey, 2015, Design and synthesis of imidazopyrazolopyridines as novel selective COX-2 inhibitors, Molecules, 20, 15287, 10.3390/molecules200815287

Renard, 2014, N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism, Eur. J. Med. Chem., 74, 12, 10.1016/j.ejmech.2013.12.033

Krejčová, 2014, Antiinflammatory and neurological activity of pyrithione and related sulfur-containing pyridine N-oxides from Persian shallot (Allium stipitatum), J. Ethnopharmacol., 154, 176, 10.1016/j.jep.2014.03.066

Renard, 2009, Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors, J. Med. Chem., 52, 5864, 10.1021/jm900702b

Pandit, 2018, Synthesis and characterization of novel imidazo[1,2-a]pyridine derivatives as potential cyclooxygenase-2 (COX-2) inhibitors, World J. Pharm. Pharm. Sci., 7, 1211

Ahmed, 2018, Screening of curcumin-derived isoxazole, pyrazoles, and pyrimidines for their anti-inflammatory, antinociceptive, and cyclooxygenase-2 inhibition, Chem. Biol. Drug Des., 91, 338, 10.1111/cbdd.13076

Graziano, 2018, Synthesis, characterization, molecular modelling and biological evaluation of thieno-pyrimidinone methanesulphonamide thio-derivatives as non-steroidal anti-inflammatory agents, Clin. Exp. Pharmacol. Physiol., 10.1111/1440-1681.12962

Roscales, 2018, Novel Valdecoxib Derivatives by Ruthenium(II)-Promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity, Med. Chem. Commun., 9, 534, 10.1039/C7MD00575J

Wiley, 1945, The chemistry of oxazoles, Chem. Rev., 37, 401, 10.1021/cr60118a002

Robinson, 1909, CCXXXII.—a new synthesis of oxazole derivatives, J. Chem. Soc., 95, 2167, 10.1039/CT9099502167

Van Leusen, 1977, Chemistry of sulfonylmethyl isocyanides. 13. A general one-step synthesis of nitriles from ketones using tosylmethyl isocyanide. Introduction of a one-carbon unit, J. Org. Chem., 42, 3114, 10.1021/jo00439a002

Cornforth, 1947, A new synthesis of oxazoles and iminazoles including its application to the preparation of oxazole, J. Chem. Soc., 96, 10.1039/jr9470000096

A.A. Siddiqui, Precise Chemistry of Natural Products and Heterocyclic Compounds, CBS Publishers & Distributors Pvt. Ltd., first ed., Page 420, 2014.

P.F. Cirillo, S. Breitfelder, U.R. Patel, J.R. Proudfoot, A.D. Swinamer, H. Takahashi, T.A. Gilmore, R. Sharma,Compounds useful as anti-inflammatory agents, US7019006B2, 28 March, 2006.

J. Haruta, H. Hashimoto, M. Matsushita, Oxazole derivatives and use thereof, US5945539A, 31 August, 1999.

J.J. Talley, S. Bertenshaw, D.J.J. Rogier, M. Graneto, D.L. Brown, B. Devadas L. Hwang-Fun, J.A. Sikorski , WO1996036617A1, 21 November, 1996.

G. Kokotos, B. Johansen, V. Magrioti, M. Tsakos, 2-oxothiazole compounds and method of using same for chronic inflammatory disorders, US9597318B2, 21 March, 2017.

M. Barreau, M. Kryvenko, M.P. Lavergne, A. Techer, Oxazole derivatives, their preparation and pharmaceutical compositions containing them, US5403852A, 04 April, 1995.

J.J. Talley, Isoxazole compounds as cyclooxygenase inhibitors, US5859257A, 12 January, 1999.

J. Haruta, H. Hashimoto, M. Matsushita, Heterocyclic aromatic oxazole compounds and use thereof, US5994381A 30 November,1999.

B.H. Norman, L.F. Lee, J.L. Masferrer, J.J. Talley, Substituted oxazolyl compounds for the treatment of inflammation, WO1994027980A1, 08 December, 1994.

J.J. Talley, S.R. Bertenshaw, D.J.J. Rogier, M.J. Graneto, Substituted oxazoles for the treatment of inflammation, US6090834A, 18 July, 2000.

T.W. Schultz, D. Korey, Amorphous oxazole coumpound and its use as cox-2 inhibitor, WO2001092238A1, 06 December, 2001.

U.K. Bandarage, R.A. Earl, M. Ezawa, X. Fang, D.S. Garvey, S.P. Khanapure, R.R. Ranatunga, S.K. Richardson, J.D. Schroeder, C.A. Stevenson, S.J. Wey, Cyclooxygenase 2 selective inhibitors, compositions and methods of use, US7087630B2, 08 August, 2006.

T. Inaba, T. Ikemoto, S. Sakata, H. Maegawa, A. Kashiwagi , Azole compound and medicinal use thereof, US7163952B2, 16 January, 2007.

Shakya, 2016, Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as on-steroidal anti-inflammatory agents, Saudi Pharm. J., 24, 616, 10.1016/j.jsps.2015.03.018

Rakesh, 2016, 3,5-Disubstituted isoxazole derivatives: potential inhibitors of inflammation and cancer, Inflammation, 39, 269, 10.1007/s10753-015-0247-5

Abraham, 2014, Synthesis of novel 2-phenyl-1,3-oxazole derivatives as non-acidic anti inflammatory agent and evaluation by in silico, in vitro and in vivo methods, Indo Am. J. Pharm. Res., 4, 03

Zhou, 2009, Design, synthesis, and in-vivo evaluation of 4,5-diaryloxazole as novel non-steroidal anti-inflammatory drug, Biol. Pharm. Bull., 32, 1986, 10.1248/bpb.32.1986

Chilumula, 2013, Synthesis and screening of methyl-2-(2-(arylideneamino) oxazole-5-ylamino) benzoxazole-5-carboxylate derivatives as cyclooxygenase inhibitors, Int. J. Pharm. Bio Sci., 3, 32

Barton, 1985, A new synthesis of pyrroles from nitroalkenes, J. Chem. Soc., Chem. Commun., 16, 1098, 10.1039/c39850001098

Trofimov, 2010, New Intermediates for Organic Synthesis based on Acetylene, Z Chem, 26, 41, 10.1002/zfch.19860260202

Knorr, 1884, Synthese von Pyrrolderivaten, Ber Dtsch Chem. Ges., 17, 1635, 10.1002/cber.18840170220

Paal, 1884, Ueber die Derivate des Acetophenonacetessigesters und des Acetonylacetessigesters, Ber Dtsch Chem. Ges., 17, 2756, 10.1002/cber.188401702228

Van Leusen, 1977, Chemistry of sulfonylmethyl isocyanides. 13. A general one-step synthesis of nitriles from ketones using tosylmethyl isocyanide. Introduction of a one-carbon unit, J. Org. Chem., 42, 3114, 10.1021/jo00439a002

Piloty, 1910, Synthese von Pyrrolderivaten: Pyrrole aus Succinylobernsteinsäureester, Pyrrole aus Azinen, Ber Dtsch Chem. Ges., 43, 489, 10.1002/cber.19100430182

Huisgen, 1964, Azlactones as 1,3-dipoles; a new pyrrole synthesis, Angew. Chem. Int. Ed. Engl., 3, 135, 10.1002/anie.196401353

S. Kurakata, M. Hanai, S. Kanai, T. Kimura, Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia, US6887893B1, 03 May, 2005.

H.G. Striegel, S. Laufer, K. Tollmann, S. Tries, Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof, US6936632B2, 30 August, 2005.

T. Kimura, Y. Noguchi, A. Nakao, K. Suzuki, S. Ushiyama, A. Kawara, M. Miyamoto, 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses, US5908858A, 01 June, 1999.

A. Cappelli, M. Anzini, M. Biava, F. Makovec, A. Giordani, G. Caselli, L.C. Rovati, 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors, US7906551B2, 15 March, 2011.

I.K. Khanna, R.M. Weier, Y. Yu, Substituted pyrrolyl compounds for the treatment of inflammation, US5935990A, 10 August, 1999.

J.A. Zablocki, E.J. Tarlton, J.P. Rizzi, N.B. Mantlo, Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents, US6180643B1, 30 January, 2001.

A. Giordani, M. Biava, M. Anzini, V. Calderone, L.C. Rovati, 5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors,US9162979B2, 20 October, 2015.

H.G. Striegel, S. Laufer, K. Tollmann, S. Tries, 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy, US6867211B2, 15 March, 2005.

T. Kimura, Y. Noguchi, A. Nakao, K. Suzuki, S. Ushiyama, A. Kawara, M. Miyamoto, 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses. USRE39420E1, 05 December, 2006.

J.L. Bullington, X. Fan, P.F. Jackson, Y.M. Zhang, 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases, WO2004029040A1, 08 April, 2004.

P.D. Soldato, Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation, US5700947A, 23 December, 1997.

Battilocchio, 2013, A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity, Bioorg. Med. Chem., 21, 3695, 10.1016/j.bmc.2013.04.031

Kim, 2014, Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors, Bioorg. Med. Chem. Lett., 24, 1958, 10.1016/j.bmcl.2014.02.074

Anzini, 2013, Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors, J. Med. Chem., 56, 3191, 10.1021/jm301370e

Anzini, 2008, Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity, J. Med. Chem., 51, 4476, 10.1021/jm800084s

Biava, 2007, Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity, J. Med. Chem., 50, 5403, 10.1021/jm0707525

Biava, 2010, Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation, J. Med. Chem., 53, 723, 10.1021/jm901269y

Harrak, 2007, Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system, Bioorg. Med. Chem., 15, 4876, 10.1016/j.bmc.2007.04.050

Biava, 2011, Novel analgesic/anti-inflammatory agents: diarylpyrrole acetic esters endowed with nitric oxide releasing properties, J. Med. Chem., 54, 7759, 10.1021/jm200715n

Di Capua, 2016, Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity, Eur. J. Med. Chem., 109, 99, 10.1016/j.ejmech.2015.12.044

Chakraborti, 2010, Progress in COX-2 inhibitors: a journey so far, Curr. Med. Chem., 17, 1563, 10.2174/092986710790979980

Latha, 2013, Indole as a core antiinflammatory agent - a mini review, Chem. Sci. Rev. Lett., 2, 287

Carullo, 2016, Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009–2016), Medchemcomm., 8, 492, 10.1039/C6MD00569A